MariMed Inc.
MRMD
$0.093
-$0.002-2.11%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 157.96M | 157.86M | 156.07M | 152.15M | 148.60M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 157.96M | 157.86M | 156.07M | 152.15M | 148.60M |
| Cost of Revenue | 95.10M | 90.39M | 88.53M | 85.15M | 82.68M |
| Gross Profit | 62.87M | 67.48M | 67.54M | 67.00M | 65.92M |
| SG&A Expenses | 59.01M | 59.90M | 58.34M | 55.14M | 50.84M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 154.10M | 150.28M | 146.88M | 140.29M | 133.52M |
| Operating Income | 3.86M | 7.58M | 9.19M | 11.86M | 15.08M |
| Income Before Tax | -3.97M | -10.35M | -9.81M | -8.03M | -6.60M |
| Income Tax Expenses | 8.16M | 3.72M | 7.53M | 8.61M | 9.41M |
| Earnings from Continuing Operations | -12.13 | -14.07 | -17.34 | -16.64 | -16.01 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -37.00K | -64.00K | -38.00K | -49.00K | -24.00K |
| Net Income | -12.16M | -14.13M | -17.38M | -16.68M | -16.03M |
| EBIT | 3.86M | 7.58M | 9.19M | 11.86M | 15.08M |
| EBITDA | 14.72M | 17.95M | 19.31M | 21.20M | 23.65M |
| EPS Basic | -0.03 | -0.04 | -0.05 | -0.04 | -0.04 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| EPS Diluted | -0.03 | -0.04 | -0.05 | -0.04 | -0.04 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| Average Basic Shares Outstanding | 1.52B | 1.51B | 1.50B | 1.49B | 1.45B |
| Average Diluted Shares Outstanding | 1.52B | 1.51B | 1.50B | 1.49B | 1.45B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.99% | -0.85% | -0.74% | -0.77% | -0.80% |